Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naeun Lee"'
Autor:
Hyoeun Bang, Jeong Yeon Kim, Cheolyong Joe, Kyeonghui Kim, Younghak Bang, Hyemin Kim, Honghi Cha, Eunjoo Oh, Naeun Lee, Inkyung Shin, Seung-Jae Noh, Dae-Yeon Cho, Se-Hoon Lee, Jung Kyoon Choi
Publikováno v:
Cancer Research. 83:5475-5475
Previous biomarkers such as PD-L1 expression, tumor mutation burden (TMB), and neoantigen load have limited accuracy in predicting responses to immune checkpoint inhibitor (ICI) therapy. In this work, we propose an improved predictor of ICI responses
Autor:
Hyunsu Kim, Sehhoon Park, Kyoung-Yeon Han, Naeun Lee, Hyemin Kim, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee, Woong-Yang Park
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e005509
BackgroundImmune checkpoint inhibitors (ICIs) are an essential treatment for non-small cell lung cancer (NSCLC). Currently, the tumor-related intrinsic factors in response to ICIs have mostly been elucidated in tissue samples. However, tissue immune
Autor:
Sehhoon Park, Jun-Kyu Kang, Hwang-Phill Kim, Su Yeon Kim, Naeun Lee, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee
Publikováno v:
Journal of Clinical Oncology. 40:8569-8569
8569 Background: The current standard of care (SOC) for limited disease (LD) small cell lung cancer (SCLC) is definitive concurrent chemoradiotherapy (CCRT). Despite the high response rate to SOC, up to 70% of the patients potentially experience dise
Autor:
Riri Kwon, Bong-Ki Hong, Kang-Gu Lee, Eunbyeol Choi, Laurent Sabbagh, Chul-Soo Cho, Naeun Lee, Wan-Uk Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Checkpoint blockade immunotherapy (CBT) can induce long-term clinical benefits in patients with advanced cancer; however, response rates to CBT vary by cancer type. Cancers of the skin, lung, and kidney are largely responsive to CBT, while cancers of
Autor:
Kang-Gu Lee, Eunbyeol Choi, Wan-Uk Kim, Laurent Sabbagh, Naeun Lee, Chul-Soo Cho, Riri Kwon, Bong-Ki Hong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundClinical efficacy of T cell-based cancer immunotherapy is limited by the lack of T cell infiltration in the tumor mass, especially in solid tumors. Our group demonstrated previously that leukocyte-specific protein 1 (LSP1), an intracellular
Autor:
Boyeon Choi, Sang-Hoon Song, Sooyeun Lee, Chul-Ho Jeong, Dong-Joon Kim, Naeun Lee, Won-Jun Jang
Publikováno v:
Oncotarget
// Won-Jun Jang 1, * , Boyeon Choi 1, * , Sang-Hoon Song 1 , Naeun Lee 1 , Dong-Joon Kim 2 , Sooyeun Lee 1 and Chul-Ho Jeong 1 1 College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea 2 China-US (Henan) Hormel Cancer Institute, Zhen